Avi Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Avi Biopharma Inc
TickerSRPT
CIK #0000873303
CUSIP803607100
SectorLife Sciences - Pharmaceutical Preparations
Address3450 Monte Villa Parkway Suite 101, Bothell, WA 98021
Source [EDGAR]
CIK Filing 2011 - 2025
[0000873303] 10-K
[0000873303] 10-Q
[0000873303] 3
[0000873303] 4
[0000873303] 5
[0000873303] 8-K
[0000873303] D
[0000873303] SC 13D
[0000873303] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
D E Shaw & Co LP Sarepta Therapeutics Inc [2025-07-25] 0.0
Sarepta Therapeutics Inc Arrowhead Pharmaceuticals Inc [2025-02-14] 0.0
Capital International Investors Sarepta Therapeutics Inc [2024-02-09] 5.1
Sands Capital Management LLC Sarepta Therapeutics Inc [2022-02-14] 6.16
Janus Henderson Group PLC Sarepta Therapeutics Inc [2022-02-11] 8.3
Sands Capital Management LLC Sarepta Therapeutics Inc [2021-02-16] 1.24
Capital Research Global Investors Sarepta Therapeutics Inc [2021-02-10] 0.8
Sands Capital Management LLC Sarepta Therapeutics Inc [2020-02-14] 6.1
Price T Rowe Associates Inc /MD/ Sarepta Therapeutics Inc [2019-02-14] 6.1
FMR LLC Sarepta Therapeutics Inc [2018-02-09] 0.0
Capital Ventures International Sarepta Therapeutics Inc [2017-12-21] 5.4
Point72 Asset Management LP Sarepta Therapeutics Inc [2017-02-23] 5.2
Tourbillon Capital Partners LP Sarepta Therapeutics Inc [2016-10-28] 6.2
Sabby Management LLC Sarepta Therapeutics Inc [2016-05-06] 5.15
FMR LLC Sarepta Therapeutics Inc [2016-02-12] 0.0
Barry Richard Sarepta Therapeutics Inc [2015-05-05] 7.66
Point72 Asset Management LP Sarepta Therapeutics Inc [2015-05-01] 5.3
Point72 Asset Management LP Sarepta Therapeutics Inc [2014-04-30] 5.2
Perceptive Advisors LLC Sarepta Therapeutics Inc [2014-02-14] 0.45
Susquehanna Capital Group Sarepta Therapeutics Inc [2014-02-13] 5.2
Vanguard Group Inc Sarepta Therapeutics Inc [2014-02-11] 5.48
Columbia Wanger Asset Management LLC Sarepta Therapeutics Inc [2014-02-06] 7.0
BlackRock Inc Sarepta Therapeutics Inc [2014-01-30] 6.7
Sabby Management LLC Sarepta Therapeutics Inc [2013-04-24] 5.26
[2012-11-19] None
Form 3/4/5 Filer 2011 - 2025
Sarepta Therapeutics, Inc.
Arif Bilal
Rodino-Klapac Louise
Estepan Ian Michael
Wong Ryan Ho-Yan
Barry Richard
Nicaise Claude
Chambers Michael Andrew
Rothfuss Cristin
Mayo Stephen
Behrens M Kathleen
Boor Kathryn Jean
Connelly Deirdre P
Wigzell Hans Lennart Rudolf
Murray Dallan
Brown Ryan Edward
Ingram Douglas S
Ciambrone William
Gray Mary Ann
O'Neill Gilmore Neil
Martin John C
Bratica Joseph
Mahatme Sandesh
Howton David T
Cumbo Alexander
Bonney Michael W
Ruff Shamim
Basi Guriqbal S.
Kaye Edward M. MD
Stehman-Breen Catherine
Kress Jean-Paul
Wood Joan
Aphale Jayant
Price Ben Gil
Goolsbee William Alden
Hodgman John
Christopher Nishan Garabedian
Chase Anthony R
Krieg Arthur M
Martignetti Anthony
Jacobsen Michael A
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock, Inc. [2025-06-30] SOLE 11,416,108 12,115,044
Vanguard Group Inc [2025-06-30] SOLE 0 9,001,077
State Street Corp [2025-06-30] DFND 4,441,723 4,695,027
D. E. Shaw & Co., Inc. [2025-06-30] DFND 4,506,253 4,565,138
Wellington Management Group LLP [2025-06-30] DFND 0 2,530,455
Susquehanna International Group LLP [2025-06-30] OTR 180,246 2,208,046
Two Sigma Investments LP [2025-06-30] SOLE 2,161,697 2,161,697
Two Sigma Advisers LP [2025-06-30] SOLE 1,916,134 1,985,734
Geode Capital Management LLC [2025-06-30] DFND 1,858,076 1,875,997
Jane Street Group LLC [2025-06-30] DFND 1,128,477 1,633,177
Erste Asset Management GmbH [2025-06-30] SOLE 1,536,000 1,621,415
Qube Research & Technologies Ltd [2025-06-30] SOLE 1,600,372 1,600,372
Morgan Stanley [2025-06-30] DFND 1,253,888 1,486,926
Voloridge Investment Management LLC [2025-06-30] SOLE 1,474,155 1,474,155
Federated Hermes Inc [2025-06-30] DFND 1,308,193 1,308,199
Aberdeen Group plc [2025-06-30] DFND 1,242,404 1,242,404
BNP Paribas Financial Markets [2025-06-30] DFND 0 1,233,049
Caption Management LLC [2025-06-30] SOLE 1,084,600 1,084,600
Millennium Management LLC [2025-06-30] SOLE 1,062,205 1,062,205
Citadel Advisors LLC [2025-06-30] DFND 1,005,556 1,005,556
Casdin Capital LLC [2025-06-30] SOLE 990,097 990,097
Bank of America Corp /DE/ [2025-06-30] DFND 66,376 916,795
Norges Bank [2025-06-30] SOLE 913,407 913,407
Y-Intercept (Hong Kong) Ltd [2025-06-30] SOLE 870,181 870,181
Assenagon Asset Management S.A. [2025-06-30] SOLE 867,939 867,939
Ikarian Capital LLC [2025-06-30] SOLE 781,187 781,187
Dimensional Fund Advisors LP [2025-06-30] SOLE 699,989 749,092
Walleye Capital LLC [2025-06-30] SOLE 738,625 738,625
Balyasny Asset Management LP [2025-06-30] SOLE 734,728 734,728
Whitebox Advisors LLC [2025-06-30] SOLE 714,600 714,600
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com